Isolation, Characterization and In Vitro Evaluation of Novel Lytic Phages Active Against Staphylococcus aureus and Escherichia coli of Bovine Mastitis Origin-Reference-Cited by-同舟云学术

Isolation, Characterization and In Vitro Evaluation of Novel Lytic Phages Active Against Staphylococcus aureus and Escherichia coli of Bovine Mastitis Origin

Published:2024-06-14 Issue: Volume: Page:
ISSN:0369-8211
Container-title:Proceedings of the National Academy of Sciences, India Section B: Biological Sciences
language:en
Short-container-title:Proc. Natl. Acad. Sci., India, Sect. B Biol. Sci.

Author:

Badiyal Anila^ORCID,Dhial Kritika,Singh Geetanjali,Dhar Prasenjit,Sharma Mandeep,Verma Subhash^ORCID

Funder

RKVY-Govt of India

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40011-024-01621-4.pdf

Reference30 articles.

1. Tsonos J, Oosterik LH, Tuntufye HN, Klumpp J, Butaye P, De Greve H, Hernalsteens JP, Lavigne R, Goddeeris BM (2014) A cocktail of in vitro efficient phages is not a guarantee for in vivo therapeutic results against avian colibacillosis. Vet Microbiol 171(3–4):470–479. https://doi.org/10.1016/j.vetmic.2013.10.021

2. Kaur A, Singh SG, Singh V (2015) Seasonal prevalence and antibiogram profile of bacterial isolates from bovine mastitis. J Anim Res 5(3):623–629. https://doi.org/10.5958/2277-940X.2015.00105.9

3. Jingar SC, Mahendra S, Roy AK (2017) Economic losses due to clinical mastitis in cross-bred cows. J Dairy Vet Sci 3(2):555606. https://doi.org/10.19080/JDVS.2017.03.555606

4. Heikkilä AM, Nousiainen JI, Pyörälä S (2012) Costs of clinical mastitis with special reference to premature culling. J Dairy Sci 95(1):139–150. https://doi.org/10.19080/JDVS.2017.03.555606

5. Suojala L, Kaartinen L, Pyörälä S (2013) Treatment for bovine E scherichia coli mastitis—an evidence-based approach. J Vet Pharmacol Therap 36(6):521–531. https://doi.org/10.1111/jvp.12057